Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) COO Anish Patel sold 17,500 shares of the company’s stock in a transaction that occurred on Thursday, April 11th. The shares were sold at an average price of $25.03, for a total value of $438,025.00. The sale was disclosed in a document filed with the Securities & […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) was up 4.7% on Thursday . The stock traded as high as $18.12 and last traded at $18.12. Approximately 39,716 shares changed hands during mid-day trading, a decline of 81% from the average daily volume of 214,132 shares. The stock had previously closed at $17.30. Analyst Ratings […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) was up 4.7% on Thursday . The stock traded as high as $18.12 and last traded at $18.12. Approximately 39,716 shares changed hands during mid-day trading, a decline of 81% from the average daily volume of 214,132 shares. The stock had previously closed at $17.30. Analyst Ratings […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) rose 4.7% on Thursday . The stock traded as high as $18.12 and last traded at $18.12. Approximately 39,716 shares changed hands during mid-day trading, a decline of 81% from the average daily volume of 214,132 shares. The stock had previously closed at $17.30. Wall Street Analyst […]
Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) were down 3.9% during trading on Monday after an insider sold shares in the company. The company traded as low as $18.64 and last traded at $18.64. Approximately 9,380 shares traded hands during trading, a decline of 94% from the average daily volume of 144,773 […]